What's new in the treatment of atopic dermatitis?;Co nowego w leczeniu atopowego zapalenia skóry?

Postepy Dermatologii i Alergologii

Volumn 26, Issue 5, 2009, Pages 350-353

  Nowicki, Roman ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Antihistamines; Atopic dermatitis; Ciclosporin; Emollients; Epidermal barrier; Proactive therapy; Topical calcineurin inhibitors; Topical steroids

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; FILAGGRIN; IMMUNOSUPPRESSIVE AGENT;

ATOPIC DERMATITIS; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFICACY; GENETIC ASSOCIATION; HUMAN; INFECTION RATE; PATIENT EDUCATION; PROTEIN EXPRESSION; PRURITUS; SKIN FUNCTION; SKIN PERMEABILITY; STRATUM CORNEUM; SYSTEMIC THERAPY; TOPICAL TREATMENT; XEROSIS;

EID: 70849105034     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Leung DY, Nicklas RA, Li JT, et al. Disease management of atopic dermatitis: An updated practice parameter. Ann Allergy Asthma Immunol 2004; 93 (3 Suppl. 2): S1-21.
2. Williams H. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352: 2314-2324
3. Hughes R, Ward D, Tobin AM, et al. The use of alternative medicine in pediatric patients with atopic dermatitis. Pediatr Dermatol 2007; 24: 118-120 (Pubitemid 46495909)
4. Boguniewicz M. Atopic dermatitis: beyond the itch that rashes. Immunol Allergy Clin North Am 2005; 25: 333-351 (Pubitemid 40692713)
5. Simpson EL, Hanifin JM. Atopic dermatitis. Med Clin North Am 2006; 90: 149-167
6. Elias PM, Steinhoff M. 'Outside-to-inside" (and now back to 'outside') pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008; 128: 1067-1070
7. Darsow U, Lubbe J, Taieb A, et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005; 19: 286-295 (Pubitemid 40691704)
8. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-160
9. Guzik TJ, Bzowska M, Kasprowicz A, et al. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 2005; 35: 448-455 (Pubitemid 40577236)
10. Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrynogen contribute to the enhaced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001; 108: 269-274 (Pubitemid 32735412)
11. Laouini D, Kawamato S, Yalcindag A, et al. Epicutaneous sensitization with superantigen induces allergic skin inflamation. J Allergy Clin Immunol 2003; 112: 981-987 (Pubitemid 37412069)
12. Strickland I, Hauk PJ, Trumble AE, et al. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 1999; 112: 249-253 (Pubitemid 29061984)
13. Hauk PJ, Hamid QA, Chrousos GP, Leung DY. Induction of corticosteroid insensitivity in human peripheral blood mononuclear cells by microbial superantigens. J Allergy Clin Immunol 2000; 105: 782-787
14. Proksch E, Lachapelle JM. The management of dry skin with topical emollients - recent perspectives. J Dtsch Dermatol Ges 2005; 3: 768-774
15. Mihm MC, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976; 67: 305-312
16. Wollenberg A, Wen S, Bieber T. Phenotyping of epidermal dendritic cells - clinical applications of a flow cytometric micromethod. Cytometry 1999; 37: 147-155 (Pubitemid 29463484)
17. Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis and interruption of the atopic march. J Allergy Clin Immunol 2003; 112: S140-50. (Pubitemid 37550030)
18. Grimalt R, Mengeaud V, Cambazard F; Study Investigators' Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007; 214: 61-67 (Pubitemid 46033003)
19. Del Rosso J, Friedlander SF. Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol 2005; 53: S50-8. (Pubitemid 40828181)
20. Abramovits W, Goldstein AM, Stevenson LC. Changing paradigms in dermatology: Topical immunomodulators within a permutational paradigm for the treatment of atopic dermatitis and eczematous dermatitis. Clin Dermatol 2003; 21: 383-391 (Pubitemid 37543554)
21. Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-555 (Pubitemid 34234209)
22. Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients. Part I: Efficacy. J Am Acad Dermatol 2001; 44: S28-38.
23. Drake L, Prendergast M, Maher R, et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001; 44 (1 Suppl): S65-72.
24. Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001; 44 (1 Suppl): S58-64. (Pubitemid 32047913)
25. Thaci D, Reitamo S, Gonzalez Ensenat MA, et al. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol 2008; 159: 1348-1356
26. Wollenberg A, Bieber T. Proactive therapy of atopic dermatitis - an emerging concept. Allergy 2009; 64: 276-278
27. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135: 1522-1525
28. Gottlieb AB. Therapeutic options in the treatment of psoriasis and atopic dermatitis. J Am Acad Dermatol 2005; 53: S3-16.
29. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol 2004; 50: 391-404.
30. Shaw M, Morrell DS, Goldsmith LA. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD). Pediatr Dermatol 2008; 25: 19-24. (Pubitemid 351315445)